Matinas BioPharma Holdings, Inc. (MTNB) SEC Filings https://www.matinasbiopharma.com/investors/sec-filings/all-sec-filings/rss Matinas BioPharma Holdings, Inc. (MTNB) - All SEC Filings en-us https://s3.amazonaws.com/equisolve-dev4/matinasbiopharma/files/theme/images/logo-sm.png Matinas BioPharma Holdings, Inc. Logo /investors Equisolve Investor Relations Suite <![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]> https://www.matinasbiopharma.com/all-sec-filings?page=1#document-6394-0001493152-26-037748 Thu, 13 Aug 26 16:20:57 -0400 https://www.matinasbiopharma.com/all-sec-filings?page=1#document-6394-0001493152-26-037748 <![CDATA[SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership]]> https://www.matinasbiopharma.com/all-sec-filings?page=1#document-6393-0000921895-26-002111 Thu, 13 Aug 26 16:18:41 -0400 https://www.matinasbiopharma.com/all-sec-filings?page=1#document-6393-0000921895-26-002111 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.matinasbiopharma.com/all-sec-filings?page=1#document-6392-0000921895-26-002109 Thu, 13 Aug 26 16:13:38 -0400 https://www.matinasbiopharma.com/all-sec-filings?page=1#document-6392-0000921895-26-002109 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.matinasbiopharma.com/all-sec-filings?page=1#document-6391-0000921895-26-002105 Thu, 13 Aug 26 16:05:36 -0400 https://www.matinasbiopharma.com/all-sec-filings?page=1#document-6391-0000921895-26-002105 <![CDATA[425 - Prospectuses and communications, business combinations]]> https://www.matinasbiopharma.com/all-sec-filings?page=1#document-6390-0001493152-26-036000 Tue, 04 Aug 26 16:20:33 -0400 https://www.matinasbiopharma.com/all-sec-filings?page=1#document-6390-0001493152-26-036000 <![CDATA[425 - Prospectuses and communications, business combinations]]> https://www.matinasbiopharma.com/all-sec-filings?page=1#document-6389-0001493152-26-035330 Thu, 30 Jul 26 08:05:51 -0400 https://www.matinasbiopharma.com/all-sec-filings?page=1#document-6389-0001493152-26-035330 <![CDATA[425 - Prospectuses and communications, business combinations]]> https://www.matinasbiopharma.com/all-sec-filings?page=1#document-6388-0001493152-26-035183 Wed, 29 Jul 26 16:06:04 -0400 https://www.matinasbiopharma.com/all-sec-filings?page=1#document-6388-0001493152-26-035183 <![CDATA[8-K - Current report]]> https://www.matinasbiopharma.com/all-sec-filings?page=1#document-6387-0001493152-26-034601 Fri, 24 Jul 26 17:01:08 -0400 https://www.matinasbiopharma.com/all-sec-filings?page=1#document-6387-0001493152-26-034601 <![CDATA[425 - Prospectuses and communications, business combinations]]> https://www.matinasbiopharma.com/all-sec-filings?page=1#document-6386-0001493152-26-034108 Tue, 21 Jul 26 17:08:02 -0400 https://www.matinasbiopharma.com/all-sec-filings?page=1#document-6386-0001493152-26-034108 <![CDATA[425 - Prospectuses and communications, business combinations]]> https://www.matinasbiopharma.com/all-sec-filings?page=1#document-6385-0001493152-26-033590 Thu, 16 Jul 26 17:27:30 -0400 https://www.matinasbiopharma.com/all-sec-filings?page=1#document-6385-0001493152-26-033590